Last Updated on July 1, 2026 by Dr. Bhagat
Key Takeaways
- Frontiers in Bioengineering and Biotechnology holds a 5.8 Impact Factor for 2025, placing it in the Q1 quartile in Biotechnology & Applied Microbiology.
- Published by Frontiers Media SA (Switzerland), this open-access journal operates on a continuous publication model.
- The journal covers biomedical engineering, biomaterials, tissue engineering, synthetic biology, bioinformatics, bioprocess engineering, industrial biotechnology, biosensors.
- It has accumulated 56,245 total citations in the Web of Science database.
- Indexed in SCIE, PubMed Central, and Scopus with an H-index of 82.
Frontiers in Bioengineering and Biotechnology is an open-access journal publishing research at the interface of engineering and biology including biomedical engineering, biomaterials, tissue engineering, synthetic biology, and industrial biotechnology. The journal publishes rigorously peer-reviewed research at the interface of engineering and biology, covering topics in biomedical engineering, biomaterials, tissue engineering, synthetic biology, bioinformatics, bioprocess engineering, and industrial biotechnology. Established in 2014 as part of the Frontiers publishing ecosystem, it has grown into one of the leading venues for disseminating bioengineering and biotechnology research findings globally.
OVERVIEWAbout Frontiers in Bioengineering and Biotechnology Journal
| Attribute | Details |
|---|---|
| Journal Name | Frontiers in Bioengineering and Biotechnology |
| Abbreviation | FRONT BIOENG BIOTECHNOL |
| ISSN | 2296-4185 |
| Publisher | Frontiers Media SA |
| Country | Switzerland |
| Language | English |
| Publication Frequency | Continuous |
| Access Model | Open Access |
| Subject Category | Biotechnology & Applied Microbiology |
| First Year Published | 2014 |
Operating under the Frontiers Media platform, Frontiers in Bioengineering and Biotechnology employs a collaborative peer-review model where editorial decisions involve both independent reviewers and academic editors. This approach aims to balance rigor with efficiency, reducing time-to-publication while maintaining scientific standards. The journal’s editorial board includes specialists from leading research institutions across North America, Europe, and Asia.
IMPACT FACTORFrontiers in Bioengineering and Biotechnology Impact Factor
According to the 2025 Journal Citation Reports (Clarivate), Frontiers in Bioengineering and Biotechnology has earned an Impact Factor of 5.8, positioning it in Q1 within the Biotechnology & Applied Microbiology category. The Impact Factor reflects the ratio of citations received in 2025 to citable items published in 2023 and 2024.
| Metric | Value |
|---|---|
| 2025 Impact Factor | 5.8 |
| JCR Quartile | Q1 |
| Total Citations | 56,245 |
| Category | Biotechnology & Applied Microbiology |
| H-index | 82 |
The journal’s citation trajectory reflects its standing within the Biotechnology & Applied Microbiology research community. With 56,245 total citations recorded in the Web of Science Core Collection, it ranks among the actively cited journals in its discipline. The Q1 quartile placement confirms competitive positioning relative to peer journals in the same category.
METRICSFrontiers in Bioengineering and Biotechnology Journal Metrics
Beyond the Journal Impact Factor, Frontiers in Bioengineering and Biotechnology is evaluated through several bibliometric indicators that together provide a rounded view of its scholarly influence:
| Metric | Value | Source |
|---|---|---|
| CiteScore (Scopus) | 8.3 | Elsevier |
| SNIP | 1.31 | Scopus |
| SJR | 1.28 | Scopus |
| H-index | 82 | Google Scholar / Web of Science |
| Total Citations | 56,245 | Web of Science |
CiteScore measures average citations per document over a four-year window, while SNIP (Source Normalized Impact per Paper) adjusts for field-specific citation practices. SJR (SCImago Journal Rank) weights citations by the prestige of the citing journal. Together, these metrics confirm Frontiers in Bioengineering and Biotechnology as a well-cited venue in Biotechnology & Applied Microbiology.
SCOPEFrontiers in Bioengineering and Biotechnology Aim and Scope
The journal welcomes original research articles, systematic reviews, meta-analyses, methods papers, brief reports, and opinion pieces across its specialty sections. Core coverage areas include biomedical engineering, biomaterials, tissue engineering, synthetic biology, bioinformatics, bioprocess engineering, industrial biotechnology, biosensors. Interdisciplinary submissions connecting bioengineering and biotechnology research with computational biology, clinical medicine, or public health are particularly encouraged.
Section editors oversee manuscript evaluation within their domains, ensuring that accepted papers meet both disciplinary standards and broader methodological requirements. The journal also publishes registered reports and protocol papers, supporting reproducibility in bioengineering and biotechnology research.
SUBMISSIONSubmission Process
Authors must submit manuscripts through the Frontiers online editorial system. Initial screening checks for scope alignment, plagiarism, and formatting compliance before assignment to an academic editor. The collaborative peer review typically involves at least two independent reviewers per manuscript.
Accepted articles are published under open-access licenses (CC-BY), making them immediately available to the global research community. Article Processing Charges (APCs) apply and vary by article type; waivers are available for authors from low-income countries upon request.
FAQFrequently Asked Questions
What is the current Impact Factor of Frontiers in Bioengineering and Biotechnology?
Frontiers in Bioengineering and Biotechnology has a 2025 Impact Factor of 5.8, placing it in the Q1 quartile within Biotechnology & Applied Microbiology.
Who publishes Frontiers in Bioengineering and Biotechnology?
Frontiers in Bioengineering and Biotechnology is published by Frontiers Media SA, a Switzerland-based open-access publisher.
Is Frontiers in Bioengineering and Biotechnology indexed in SCIE and Scopus?
Yes, Frontiers in Bioengineering and Biotechnology is indexed in Science Citation Index Expanded (SCIE), Scopus, and PubMed Central.
What is the H-index of Frontiers in Bioengineering and Biotechnology?
Frontiers in Bioengineering and Biotechnology has an H-index of 82, reflecting the number of papers with at least that many citations.
What topics does Frontiers in Bioengineering and Biotechnology cover?
The journal covers biomedical engineering, biomaterials, tissue engineering, synthetic biology, bioinformatics, bioprocess engineering, industrial biotechnology, biosensors.
Is Frontiers in Bioengineering and Biotechnology an open-access journal?
Yes, Frontiers in Bioengineering and Biotechnology is a fully open-access journal. All articles are published under Creative Commons licenses and are freely available to readers worldwide.